Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-26-160395
Filing Date
2026-04-17
Accepted
2026-04-17 08:33:10
Documents
3
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 16686
2 EX-99.1 ck0000000000-ex99_1.pdf EX-99.1 112134
3 EX-99.2 ck0000000000-ex99_2.pdf EX-99.2 184711
  Complete submission text file 0001193125-26-160395.txt   427889
Mailing Address 1400-145 KING ST. WEST TORONTO Ontario, Canada M5H 1J8
Business Address 1400-145 KING ST. WEST TORONTO Ontario, Canada M5H 1J8 506-232-4400
ORGANIGRAM GLOBAL INC. (Subject) CIK: 0001620737 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0930
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90762 | Film No.: 26869525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 103 FOULK ROAD SUITE 111 WILMINGTON DE 19803
Business Address 103 FOULK ROAD SUITE 111 WILMINGTON DE 19803 (302) 656-1950
BT DE Investments Inc. (Filed by) CIK: 0001848200 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A